微血管减压术治疗原发性三叉神经痛临床研究  

Microvascular Decompression Treatment Primary Trigeminal Neuralgia with Clinical Research

作　　者：李国平[1] 

机构地区：[1]贵港市人民医院神经外二科,广西贵港537100

出　　处：《中国伤残医学》2012年第4期9-10,共2页Chinese Journal of Trauma and Disability Medicine

摘　　要：目的:观察微血管减压术(MVD)治疗原发性三叉神经痛(PTN)的临床疗效,研究其病因及相关因素。方法:回顾性分析43例PTN患者的病例资料,总结和分析临床治疗效果及其并发症的发生。结果:43例患者治愈38例(88.37%),显效3例(6.97%),有效1例(2.33%),无效1例(2.33%);总有效率为97.67%,随访3～18个月,有1例患者复发,无严重并发症及死亡病例。结论:微血管减压术治疗原发性原发性三叉神经痛安全有效,治愈率高,复发率低,三叉神经功能可得到有效保护,是原发性三叉神经痛较多治疗方法中理想的治疗方法。Objective： To Observe microvascular decompression of the treatment of primary trigeminal neuralgia clinical curative effect, study on etiology and correlative factors. Methods：The retrospective analysis of 43 cases of PTN patients with clinical data, summary and analysis of clinical treatment and its complications.Results： 43cases were cured 38 cases （88.37%）, effective in 3 cases （6.97%0, Effective 1 cases （2.33%,）, 1 case ineffective （2.33%）; The total effective rate was 97.67%, Follow-up of 3 -18 months, the relapse of one patient, no serious complications and deaths.Conclusion：Microvascular decompression of the treatment of primary trigeminal neuralgia might be safe and effective, Cure rate is high, the recurrence rate is low, trigeminal nerve function can get effective protection.

关 键 词：原发性三叉神经痛 微血管减压术 疗效 

分 类 号：R782[医药卫生—口腔医学]